Baricitinib and tofacitinib in patients with rheumatoid arthritis: results of regular clinical practice.

Objective: Main objective: Describe the effectiveness and safety of baricitinib and tofacitinib in patients diagnosed with rheumatoid arthritis in our hospital.

Secondary Objective: Analyse whether there are  differences between the two drugs in routine clinical practice.

Method: Two-year retrospective study of patients diagnosed with  rheumatoid arthritis treated in our hospital with baricitinib and tofacitinib  for at least 6 months.